regeneron glp-1 Readout Newsletter: Abeona, Pfizer, Regeneron, AstraZeneca Announcing an in-licensing agreement for

While GLP-1 therapies are known for achieving greater weight loss compared to controls, they often come with side effects like nausea, vomiting, and dizziness, which lead many patients to stop treatment prematurely

Protein-rich foods and healthy fats (especially omega-3 fatty acids) activate nutrient-sensing receptors on intestinal L-cells that produce GLP-1

Shima Hadidchi, MD provides individualized evaluation, monitoring, and support to ensure safe and effective outcomes

Understanding these potential pathways helps contextualize the limited available evidence and identify areas requiring further investigation

The scale moves first, and the mindset follows